VLA 0.00% $1.75 viralytics limited

Broker upgrade, page-23

  1. 1,603 Posts.
    lightbulb Created with Sketch. 107
    Phmurph, I'm suggesting they license Cavatak for one of the cancer types (eg. bladder) at $200m. Imagine the return on separate licences for  (how many cancer types are there again?)

    But this is just my daydream. No one else has to buy into it!
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.